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Abstract
Objective: The Dietary Inflammatory Index (DII)TM, which was developed to
characterize the inflammatory potential of a person’s diet, has been shown to be
associated with inflammatory conditions such as cancer. The present study aimed
to investigate the association between DII scores and colorectal adenoma (CRA),
a pre-cancerous condition.
Design: Responses to baseline dietary questionnaires were used calculate DII
scores. In a cross-sectional study design, the association between DII scores and
CRA prevalence was determined in men and women separately using logistic
regression models.
Setting: Ten cancer screening centres across the USA.
Subjects: Participants were those included in the screening arm of the Prostate,
Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Results: Among the 44 278 individuals included in these analyses, men with diets
in the most inflammatory quartile of DII scores had higher odds of all types of
CRA (advanced, non-advanced and multiple (>1)) compared with those with diets
in the least inflammatory quartile of DII scores. In fully adjusted models, compared
with those with DII scores in quartile 1 (least inflammatory), males with DII
scores in quartile 3 (adjusted odds ratio (aOR)= 1·28; 95% CI 1·12, 1·47) and
quartile 4 (aOR= 1·41; 95% CI 1·23, 1·62) were more likely to have prevalent distal
CRA. Higher DII scores, representing a more inflammatory diet, also were weakly
associated with a higher prevalence of CRA in women.
Conclusions: Implementing an anti-inflammatory diet may be an effective means





The biological effects of diet on inflammation are com-
plex. Very simply, oxidative stress, which can occur after
the ingestion of an energetically dense (i.e. high in fat
or high in simple carbohydrates) meal, results in the
production and release of free radicals and reactive
oxygen and nitrogen species into the tissues. This in turn
can lead to damaged tissues and inflammation(1,2).
Conversely, foods high in antioxidants and flavonoids,
such as fruits and vegetables, reduce inflammation by
scavenging free radicals, inhibiting pro-oxidant enzymes,
binding free radicals and possibly modulating the
expression of pro-inflammatory molecules(3,4). Prolonged
and unchecked inflammatory conditions create a micro-
environment favourable for tumour growth and progres-
sion(5). Identifying dietary factors that promote a less
favourable environment for inflammatory conditions, in
light of the association between diet and inflammation,
may be one way to minimize the incidence of adenomas
and cancer.
The Dietary Inflammatory Index (DII)TM was developed
to characterize the inflammatory nature of a person’s diet,
with scores on a continuum from maximally inflammatory
to maximally anti-inflammatory. This index has been
shown to be associated with concentrations of several
circulating inflammatory proteins, including C-reactive
protein(6) and IL-6(7), in prospective and case–control
studies. Previously published work has shown that
a more inflammatory diet, as reflected by a higher DII
score, is associated with a higher prevalence of asthma
(an inflammatory condition)(7), pancreatic cancer(8) and
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prostate cancer(9) in hospital-based case–control studies.
Most recently, higher scores on this index have been
found to be associated with a higher incidence of colo-
rectal cancer in the Women’s Health Initiative and the Iowa
Women’s Health Study(10,11). Another recent study showed
an association between DII scores and polymorphisms
in the gene for the anti-inflammatory cytokine IL-4
(rs2243250)(12). In that study, individuals with a more
inflammatory diet and the IL-4 polymorphism had a higher
risk of colorectal cancer than those with the polymorphism
who consumed a less inflammatory diet. Less favourable
DII scores are reflective of diets lower in antioxidants
and higher in pro-oxidants. This imbalance could lead to
oxidative stress and genotoxic damage, which may then
lead to abnormal growths and cancers in the colon(13).
Anti-inflammatory dietary factors exert their effects
through the modulation and inhibition of inflammatory
proteins and cytokines, such as transforming growth
factor-β, cyclooxygenase-2, IFN-γ and NF-κB(14).
While these studies have shown an association between
the incidence of colorectal cancer and a more inflammatory
diet, it is unknown whether colorectal adenomas (CRA),
which are precursors for colorectal cancer, are associated
with a more inflammatory diet. The purpose of the current
study was to examine whether or not a more inflammatory
diet, as indicated by a higher DII score, was associated with
the prevalence of CRA in a large cohort of older adults.
Methods
Study population
Data were collected as part of the Prostate, Lung, Colorectal,
and Ovarian (PLCO) Cancer Screening Trial and have been
described previously in detail(15–18). In short, over 148 000
men and women, aged 55–74 years, were recruited between
1993 and 2000 at one of ten screening centres across the
USA (Birmingham, AL; Denver, CO; Detroit, MI; Honolulu,
HI; Marshfield, WI; Minneapolis, MN; Pittsburgh, PA; Salt
Lake City, UT; St Louis, MO; and Washington, DC). Each
participant who was randomly assigned to the screening
arm was asked to complete a detailed questionnaire at
baseline with questions regarding sociodemographic
characteristics, diet, physical activity, personal and family
cancer history, smoking history and use of selected
medications. Those with an abnormal finding on flexible
sigmoidoscopy examination were referred for endoscopic
follow-up. Results from diagnostic screening and treatment,
including surgical procedures, were gathered by trained
medical abstractors from each participant’s medical record.
Institutional review board approval was obtained from the
National Cancer Institute and the ten screening centres
involved with the study. Informed consent was provided
by all study participants.
Data from screening-arm participants who returned the
baseline questionnaire, which had questions regarding
sociodemographic information, health history, medica-
tions and physical activity, were used for the present
secondary analyses (n 75 611). Participants were excluded
in this order: if flexible sigmoidoscopy examination was
not adequate (defined as insertion to at least 50 cm with
>90% of mucosa visible or suspect lesion found) or not
done (n 18 148); had a positive flexible sigmoidoscopy
examination but had either no follow-up or ambiguous
follow-up (n 3717); had a personal history of any cancer
(except melanoma) or did not know their personal history
of cancer before the dietary questionnaire (n 2081); had
ulcerative colitis, Crohn’s disease, Gardner’s syndrome or
familial polyposis (n 652); did not complete the dietary
questionnaire (n 4937); had eight or more missing
responses on the dietary questionnaire (n 385); had
extreme energy intake reported on the dietary ques-
tionnaire (top or bottom 1% of sex-specific energy intake;
n 796); or did not specify race (n 9). Participants were
further excluded if they were missing data on key
variables (BMI, education, physical activity or smoking
status; n 23). The final sample size was 44 278.
Adenomas
Any prevalent adenoma, not including hyperplastic
polyps, in the distal region (rectum to the splenic flexure)
at baseline was the main outcome of interest. Advanced
adenomas were those that were villous or tubulovillous
in nature, large (≥1·0 cm), or displayed severe or high-
grade dysplasia. Physician and non-physician examiners




Dietary data were collected using the dietary ques-
tionnaire developed by the National Cancer Institute(19).
The sixteen-page questionnaire asked about the usual
frequency and portion size of 137 food items and ten
dietary supplements over the year prior to enrolment. The
dietary questionnaire has been shown to have good
reliability and has been validated against both the Block
and Willett FFQ(19). Values for daily nutrients and food
groups were determined from the national dietary data
and the Pyramid food group servings database from the
1994–1996 Continuing Survey of Food Intakes by Indivi-
duals with a method developed by Subar et al.(19).
Dietary Inflammatory Index
The DII is a tool used to score the inflammatory nature
of an overall diet and was developed using data from
individuals consuming diverse diets(20). Forty-five food/
nutrient parameters were identified in the original index as
being associated with six cytokines important in deter-
mining inflammatory response. Design and development
of the DII have been described in detail previously(20,21).
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To calculate the DII score, dietary intake data from each
participant in the PLCO cohort were linked to a previously
developed global database that was created by calculating
the global mean and global standard deviation for each of
the forty-five foods/nutrients for eleven countries around
the world(21). A Z-score for each dietary factor was
created for each PLCO participant by subtracting the
global standard mean from the individual’s reported
amount of consumed food/nutrient, and dividing this
value by its respective global standard deviation. This
value was then converted to a percentile score to minimize
the effect of ‘right skewing’ (fewer observations with
higher intakes of dietary factors), which often occurs
with dietary data.
The ‘inflammatory effect score’ for each dietary factor
was calculated previously, based on results from experi-
mental, prospective cohort, case–control, cross-sectional,
animal experimental and cell-culture studies(21). The
dietary factor percentile score for each participant in the
PLCO cohort was multiplied by its respective ‘inflamma-
tory effect score’ to derive a ‘food-specific dietary inflam-
matory score’. Each of the ‘food-specific dietary
inflammatory scores’ were summed to derive an overall
dietary inflammatory score, where negative scores are less
inflammatory and positive scores are more inflammatory.
Scores are based on both food and nutrient intakes. For
these analyses, thirty-seven of the forty-five foods or
nutrients from the original DII were available for use.
Pro-inflammatory dietary factors included: vitamin B12,
carbohydrate, cholesterol, energy, total fat, Fe, protein,
SFA and trans-fat. Anti-inflammatory dietary factors
included: vitamin B6, β-carotene, caffeine, fibre, folic acid,
vitamins A, D, C and E, niacin, riboflavin, thiamin, Mg, Se,
Zn, MUFA, n-3 fatty acids, n-6 fatty acids, PUFA, flavan-
3-ols, flavones, flavonols, flavonones, anthocyanidins,
isoflavones, green/black tea, alcohol and onion. DII scores
were calculated per 4184 kJ consumed to account for
inter-individual differences in energy intake, which is also
termed the Energy-Density DII (E-DII). E-DII scores for the
PLCO screening-arm population ranged between −5·87
(maximally anti-inflammatory) and 5·58 (maximally
pro-inflammatory). For analytical purposes, the E-DII
scores were then categorized into quartiles.
Covariate data
Potential covariates included: smoking (never, current, or
former); sex (male or female); self-report of race (black,
white, Asian or other); and non-steroidal anti-inflammatory
use (regular use of aspirin/aspirin-containing or ibuprofen/
ibuprofen-containing products or not). BMI (= [weight
(kg)]/[height (m)]2) was categorized as underweight
(<18·5kg/m2), normal (18·5–24·9kg/m2), overweight (25·0–
30·0kg/m2) or obese (>30·0kg/m2), and was based on self-
reported height and weight. Physical activity was categorized
as vigorous activities for <2h/week (low) v. ≥2h/week
(high) to stay consistent with current recommendations(22).
Hormone status was categorized as never, current (ever
taken or currently taking female hormones), former or
unknown. Education was categorized into less than high
school, high-school diploma, some college or post high-
school training, and college or graduate degree. Age at
randomization, alcohol intake (g/d), fibre intake (g/d), Ca
intake (food and supplements; mg/d) and energy intake
(kJ/d; kcal/d) were left as continuous variables.
Statistical analysis
Means and frequencies, with their respective standard
deviations and percentages, were calculated for con-
tinuous and categorical characteristics, stratified by E-DII
score quartiles. The χ2 test and ANOVA were used to
determine differences, if any, in descriptive characteristics
between quartiles of E-DII score. Normal distribution was
assessed with histograms (QQ plot or Shapiro–Wilk test)
for each variable.
Multivariable logistic regression was used to calculate the
odds of prevalent CRA for different quartiles of E-DII
score(9). Separate models were created for adenoma type
(all prevalent, advanced, non-advanced or multiple (>1)
adenoma). Regression models were initially adjusted for sex,
race, smoking, age, physical activity, education, hormone
status, regular use of aspirin/aspirin-containing or ibupro-
fen/ibuprofen-containing products, and daily Ca, energy
and alcohol intakes. Additionally, an interaction term for
sex and E-DII score category was included. All potential
covariates and interaction terms were included in the initial
model and then were evaluated for variable selection; if they
were not significant in the model (P< 0·20), they were
removed if their exclusion did not result in a lower Akaike
information criterion statistic(23). The most parsimonious
model, indicated by a lower Akaike information criterion
value, was selected. Covariates used in calculating the
overall adenoma odds were used for subgroup analyses.
The models were stratified by sex if the interaction between
sex and E-DII score was significant (P< 0·20). Wald χ2 was
used to test for trends across E-DII categories. Models were
also stratified by BMI status (overweight/obese v. normal/
underweight) or smoking status (never v. former/current).
All analyses were performed using the statistical software
package SAS version 9.4 using a P value <0·05 to indicate
significance, unless otherwise indicated.
Results
Descriptive characteristics for the quartiles of the E-DII are
presented in Table 1. Compared with quartile 4, quartile 1
(least inflammatory) had a higher percentage of females
(65·0 v. 26·0%), Asians (7·4 v. 1·6%), individuals with a
college education (45·5 v. 27·7%), individuals with a high
amount of physical activity (68·2 v. 42·4%), never smokers
(52·4 v. 40·8%) and individuals with a normal BMI (41·5 v.
22·4%). Women in quartile 1 (least inflammatory) were
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more likely to be current hormone users than women in
quartile 4 (most inflammatory; 56·6 v. 46·3%). Addition-
ally, compared with those in quartile 4, those in quartile 1
were older (62·9 v. 61·7 years), had a higher intake of
Ca (1349·7 v. 1168·4mg/d) and a lower energy intake
(7684·3 v. 9939·9 kJ/d).
Prevalent distal adenoma
There was significant interaction between E-DII score and
sex (P= 0·02), so models for prevalent distal adenoma
were stratified by sex. In fully adjusted models (adjusted
for race, education, smoking status, BMI, age and Ca
intake), compared with those with E-DII scores in quartile
1 (least inflammatory), males with E-DII scores in quartile
3 (adjusted odds ratio (aOR)= 1·28; 95% CI 1·12, 1·47) and
quartile 4 (aOR= 1·41; 95% CI 1·23, 1·62; Table 2) were
more likely to have prevalent distal CRA. Males with E-DII
scores in quartile 3 (aOR= 1·34; 95% CI 1·12, 1·60) and
quartile 4 (aOR= 1·42; 95% CI 1·19, 1·68) also were more
likely to have a non-advanced adenoma, compared with
those in the lowest quartile of E-DII scores. Males with
E-DII scores in quartile 4 (aOR= 1·39; 95% CI 1·13, 1·71;
Table 1 Baseline characteristics of the screening-arm participants (n 44278) by quartile of Energy-Density Dietary Inflammatory Index











Characteristic n % n % n % n %
Categorical variables
Sex
Male 3879 35·0 5273 47·6 6444 58·2 8192 74·0
Female 7190 65·0 5797 52·4 4625 41·8 2878*** 26·0
Race
White 9625 87·0 10107 91·3 10141 91·6 10195 92·1
Black 400 3·6 364 3·3 402 3·6 442 4·0
Asian 815 7·4 381 3·4 284 2·6 183 1·6
Other 229 2·1 218 2·0 242 2·2 250*** 2·3
Education
College 5034 45·5 4389 39·6 4012 36·2 3067 27·7
Some college 3616 32·7 3815 34·5 3732 33·7 3820 34·5
High school 2034 18·4 2290 20·7 2644 23·9 3042 27·5
Less than high school 385 3·5 576 5·2 681 6·2 1141*** 10·3
Physical activity†
High 7545 68·2 6678 60·3 5957 53·8 46949 42·4
Low 3524 31·8 4392 39·7 5112 46·2 6367*** 57·6
Smoking
Never 5801 52·4 5703 51·5 5214 47·1 4512 40·8
Current 569 5·1 759 6·9 1068 9·6 1746 15·8
Former 4694 42·4 4608 41·6 4787 43·2 4812*** 43·5
Anti-inflammatory use‡
Yes 2272 20·5 2187 19·8 2254 20·4 2216 20·0
No 8797 79·5 8883 80·2 8815 79·6 8854 80·0
Hormone therapy (females)
Current 4069 56·6 3083 53·2 2377 51·4 1331 46·3
Former 1115 15·5 908 15·7 715 15·5 468 16·3
Never 1976 27·5 1779 30·7 1513 32·7 1064 37·0
Unknown 23 0·3 20 0·4 17 0·4 9*** 0·3
BMI (kg/m2)
0–18·5 100 0·9 70 0·6 59 0·5 40 0·4
18·5–25·0 4592 41·5 3725 33·6 3223 29·1 2478 22·4
25·0–30·0 4318 39·0 4819 43·6 4973 44·9 5194 46·9
>30·0 2059 18·6 2453 22·2 2814 25·4 3358*** 30·3
Missing (n 430)
Mean SD Mean SD Mean SD Mean SD
Continuous variables
Age (years) 62·9 5·4 62·8 5·3 62·4 5·2 61·7*** 5·1
Ca intake (supplements and food; mg/d) 1349·7 578·6 1256·2 587·9 1212·1 601·5 1168·4*** 641·6
Energy intake (kJ/d) 7684·3 2717·9 8203·2 3026·7 8758·8 3273·1 9939·9*** 3811·6
Alcohol intake (g/d) 8·4 14·1 9·0 17·0 10·9 21·0 15·9*** 34·9
Fibre intake (g/d) 26·8 10·8 24·7 10·1 22·6 9·3 19·9*** 8·1
***P< 0·0001; χ2 test for categorical and ANOVA for continuous variables.
†Vigorous activities for <2 h/week (low) v. ≥2 h/week (high).
‡Regular use of aspirin/aspirin-containing or ibuprofen/ibuprofen-containing products or not.
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Table 2) were more likely to have advanced CRA, com-
pared with those with E-DII scores in quartile 1. Males
with E-DII scores in quartile 3 (aOR= 1·32; 95% CI 1·01,
1·72) and quartile 4 (aOR= 1·63; 95% CI 1·26, 2·11) were
more likely to have more than one distal CRA, compared
with those with E-DII scores in quartile 1. In fully adjusted
models, there were no differences in the odds of CRA
(advanced, non-advanced or multiple (>1)) between
E-DII quartile 1 and E-DII quartile 4 in females. However,
there was a trend that higher E-DII scores were associated
with higher odds of adenoma, overall.
When results were stratified by smoking status or BMI
classification, the odds of adenoma among overweight/
obese men with the most inflammatory diet v. those with
the least inflammatory diet (aOR= 1·39; 95% CI 1·18, 1·63)
were similar to those of normal/underweight men
(aOR= 1·50; 95% CI 1·14, 1·96; data not shown).
However, the odds of adenoma among male smokers with
the most inflammatory diet v. the least inflammatory diet
(aOR= 1·63; 95% CI 1·38, 1·93) were higher than those of
men who did not smoke (aOR= 1·22; 95% CI 0·97, 1·53;
data not shown). Females showed similar patterns
(smokers aOR= 1·43; 95% CI 1·12, 1·83; non-smokers
aOR= 0·97; 95% CI 0·76, 1·25; data not shown).
Discussion
In this large cohort of men and women, enrolled as part of
the PLCO screening arm, we sought to investigate the
association between CRA and E-DII score and found that
a more inflammatory diet was associated with distal CRA
prevalence in men, and to a limited extent in women.
Specifically, males who consumed a more inflammatory
diet were more likely to have non-advanced adenomas,
advanced adenomas and multiple (>1) adenomas than
men who consumed a less inflammatory diet.
It is believed that inflammation promotes an environment
that increases genetic mutations and disables the mechan-
isms that repair these errors(24). There also is evidence that
inflammation may promote growth factors that enhance
tumour growth, particularly through enhanced angiogen-
esis(22). Further, a vicious cycle is created in that tumour
cells produce cytokines that attract leucocytes, which fur-
ther promote inflammation(5). Higher systemic concentra-
tions of inflammatory cytokines may then lead to the
development of CRA(25). Diet can affect systemic inflam-
mation both positively and negatively. A high intake of
energy and certain types of fat (e.g. trans-fats) may lead to
pro-inflammatory states(26,27), while fruits and vegetables
Table 2 Associations between prevalent colorectal adenoma and quartile of Energy-Density Dietary Inflammatory Index (E-DII) score† in
the screening-arm participants (n 44255) by sex‡; Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, USA, 1993–2000
Quartile 1 (least




inflammatory; reference) OR 95% CI OR 95% CI OR 95% CI P trend
Men (n 23 788)§
All distal adenoma <0·0001
No. of cases 327 496 741 1091
Multivariable-adjusted OR (95% CI) 1·00 1·06 0·92, 1·23 1·28 1·12, 1·47 1·41 1·23, 1·62
Non-advanced adenoma 0·0002
No. of cases 193 310 449 630
Multivariable-adjusted OR (95% CI) 1·00 1·14 0·95, 1·38 1·34 1·12, 1·60 1·42 1·19, 1·68
Advanced adenoma 0·0003
No. of cases 129 184 284 441
Multivariable-adjusted OR (95% CI) 1·00 0·97 0·77, 1·22 1·21 0·98, 1·50 1·39 1·13, 1·71
Multiple adenomas (>1) 0·0004
No. of cases 80 136 193 327
Multivariable-adjusted OR (95% CI) 1·00 1·18 0·89, 1·56 1·32 1·01, 1·72 1·63 1·26, 2·11
Women (n 20 467)║
All distal adenoma 0·03
No. of cases 469 358 356 225
Multivariable-adjusted OR (95% CI) 1·00 0·90 0·78, 1·04 1·13 0·98, 1·31 1·08 0·91, 1·29
Non-advanced adenoma 0·07
No. of cases 291 222 217 142
Multivariable-adjusted OR (95% CI) 1·00 0·92 0·77, 1·10 1·14 0·95, 1·38 1·17 0·94, 1·45
Advanced adenoma 0·29
No. of cases 177 132 135 83
Multivariable-adjusted OR (95% CI) 1·00 0·86 0·68, 1·08 1·09 0·86, 1·38 0·96 0·72, 1·27
Multiple adenomas (>1) 0·06
No. of cases 91 60 69 57
Multivariable-adjusted OR (95% CI) 1·00 0·77 0·55, 1·07 1·08 0·79, 1·49 1·28 0·90, 1·82
Significant (P< 0·05) results are indicated in bold font.
†Quartile 1, E-DII<−2·93; quartile 2, E-DII=−2·93 to −1·80; quartile 3, E-DII=−1·81 to −0·45; quartile 4, E-DII>−0·45.
‡Interaction P values for sex × E-DII score for adenoma (overall), non-advanced adenoma, advanced adenoma and multiple (>1) adenoma are, respectively,
0·03, 0·16, 0·20 and 0·29.
§Adjusted for BMI, education, smoking status, race, Ca intake, alcohol intake and age.
║Adjusted for BMI, smoking, race, hormone status, total daily energy intake, Ca intake, alcohol intake and age.
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contain antioxidants that counteract inflammation(28). The
DII has recently been developed as a way for researchers to
characterize the overall inflammatory nature of diet(6). This
index has been shown to be associated with inflammatory
conditions, such as colon, prostate and pancreatic cancers,
and asthma(8,9,11,12,29), as well as circulating inflammatory
proteins(6,7).
Findings of the present study are generally consistent
with those from other studies that have found lower odds
of prevalent CRA among those who consume a ‘healthy’
diet(29,30). For example, men with higher scores on several
dietary indices (Healthy Eating Index, Mediterranean diet,
Dietary Approach to Stop Hypertension) were less likely
to have a prevalent CRA compared with men consuming a
less healthy diet(29). These results suggest that there may
be a common element, such as an anti-inflammatory
dimension, among the dietary indices which confers
adenoma-protective effects, and that the specific type of
diet may be less important than this common beneficial
element (e.g. anti-inflammatory dimension). Indeed, for
several of the dietary indices mentioned, better scores
have been associated with lower concentrations of
inflammatory markers(31,32).
It is interesting that lower E-DII scores, indicating a
less-inflammatory diet, were not strongly associated
with distal CRA prevalence in women, although there
was a trend across quartiles of higher odds of CRA
with higher E-DII scores. Some previous studies have
shown that women with more inflammatory diets, as
reflected by higher DII scores, were more likely to have
developed colorectal cancer, compared with those with
less inflammatory diets(10,11). However, another larger
study using individuals in the American Association of
Retired Persons Diet and Health Study found that the
association between a less inflammatory diet and lower
risk of colorectal cancer was significant only in men(33).
Since adenomas are precursors to cancer, we expected
to find a positive association between E-DII scores
and CRA prevalence in women. However, dietary
predictors for adenomas may not be the same as dietary
predictors for colon cancer in women. It has been
estimated that only half of studies on the association
between diet indices (e.g. Mediterranean diet and Healthy
Eating Index) and colorectal cancers report sex-specific
risks(34), suggesting that the current literature may not
fully capture the effects of diet on adenoma prevalence
or cancer incidence in males and females, individually.
Of those studies that have reported on dietary factors
for CRA in men and women separately, several did not
find a protective effect of diet in women(29,30,35). Another
explanation for the discrepancy in findings between the
current study and previous studies may have to do
with lower (less inflammatory) E-DII scores in the
present study (−2·1 (SD 1·6) v. −0·9 (SD 2·0); P< 0·0001(11)).
The generally lower scores in the present study may
have limited the ability to see beneficial dietary effects
because the diets were generally ‘adequate’ for adenoma
prevention.
To further explore the association between E-DII scores
and adenoma status in women, sensitivity analyses were
performed combining quartiles 1 and 2 and comparing
the odds of adenoma with those of quartile 3 or 4. Alter-
natively, cut points used in another study using the E-DII
also were used(9). In both instances, results were similar to
those presented in Table 2. The results appear to have
a curvilinear response in women, which may suggest
a differential effect of diet between sexes. A possible
explanation is that these analyses were cross-sectional
in nature and those who were consuming the most
anti-inflammatory diet were doing so because they had
concerns about a higher risk of adenoma. Another
possible explanation is that women who have very
anti-inflammatory diets also engage in other behaviours
not fully accounted for in the analyses, which weaken the
effect of a healthy diet, or because women misestimate
their actual intake because of social desirability and under-
report total fat and energy intakes(36). Differences in actual
v. reported intakes between men and women may also
at least partly explain why the E-DII was associated with
adenoma in men but not in women.
It is unknown to what extent the results of the current
study can be applied to proximal adenomas. One study
found that the risk adenoma and diet (fibre and fruit and
vegetables) was lower for adenomas occurring in the
proximal v. distal region(37). However, results from other
studies, including a literature review, are unclear as to
whether or not there are anatomical site differences in
the effects of diet on cancer or adenoma development or
occurrence(33,38,39). Future research would need to be
done to more fully understand the association between
diet and adenoma occurrence in site-specific areas.
One of the strengths of the present study is the large,
diverse cohort of individuals with varied dietary habits,
enabling the analysis of adenoma outcomes across a broad
spectrum of food intakes. Another study strength is the
novel way to characterize the inflammatory nature of diet.
Inflammation is an important factor in disease occurrence
and the E-DII is the first index to be developed specifically
for measuring the inflammatory potential of an individual’s
diet. Finally, participants in the PLCO study were screened
uniformly, allowing for equal opportunity of adenoma
detection.
A limitation of the study is that the E-DII was not able to
fully determine the inflammatory nature of the diets due
to some of the E-DII components not being included in
the dietary questionnaire (e.g. eugenol, garlic, ginger,
saffron, turmeric, pepper, rosemary and thyme/oregano).
However, most items for the E-DII were included in the
calculations and these represented the most commonly
consumed foods/nutrients. Another limitation to these
analyses is recall bias, most notably for the dietary recall.
This may have resulted in biased estimates, particularly
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among women where the potential for misclassification
was greater, thus resulting in estimates closer to the null.
Conclusion
A more inflammatory diet was associated with a higher
risk of CRA, particularly in men. The results for women
were less conclusive. Therefore, future research should
use large prospective studies to replicate these findings
with a focus on gender differences and the potential for
recall bias in influencing these associations. Also, future
work could be done to determine whether these results
apply to incident or recurrent adenomas, as well as ade-
nomas in the proximal region of the colon. Results from
the present study support an inflammatory mechanism for
the development of CRA. From a public health perspec-
tive, future work should focus on helping individuals
understand and incorporate anti-inflammatory elements
into their diet.
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